Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 184% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 19.9% — good return on equity
- Revenue growing at 11% annually
BADGER METER, INC. (BMI) is a Healthcare company operating in Totalizing Fluid Meters & Counting Devices, listed on the NYSE , with a market capitalisation of $4.3 billion . Key value metrics: P/E ratio 30.2, P/B ratio 6.00, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
BADGER METER, INC. — Fundamental Analysis Summary
BADGER METER, INC. (BMI) is currently trading 184% above its Graham Number of $51.67, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 30.2x.
On financial health, BMI shows a moderate Piotroski F-Score of 5/9, and solid return on equity of 19.9% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.00.
StockPik's composite Value Score for BMI is 49/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
BMI reports a solid gross margin of 42.3% (sector average: 33.5%) and a strong operating margin of 20.0%.
BMI shows revenue growing at 11% year-over-year, with earnings growing at 13%.
BMI pays a modest dividend yield of 1.0%.